Robyn Schecter

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Multiple Sclerosis

Ejection Fraction

Prognostic Factors

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Hamid Reza Nakhaipour, Umakanth Vudumula, Vivek Khurana, Guillaume Sébire, Jean K Mah, Daniela Pohl, Robyn Schecter, Nicholas Adlard
Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada. Journal of medical economics 23 (12) (2020)
Pierre Duquette, Michael Yeung, Soukaïna Mouallif, Hamid Reza Nakhaipour, Paola Haddad, Robyn Schecter
A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies. PloS one 14 (1) (2019)